On July 18, 2025, the Federal Court issued an update to its “Case and Trial Management Guidelines for Complex Proceedings, Proceedings under the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations), and Appeals under subsection 56(1) of the Trademarks Act” (the Guidelines), effective immediately. The updates particularly relate to appeals of the Registrar of Trademarks under subsection 56(1) of the Trademarks Act (the Act).
The Guidelines introduce requirements for parties seeking judicial review of a decision made by the Trademarks Opposition Board (TMOB) and set out steps for seeking leave to file additional evidence under subsection 56(5) of the Act. Prior to the amendments to subsection 56(5) of the Act requiring leave to appeal (which came into force on April 1, 2025), applicants could file additional evidence on appeal as of right.
The Guidelines state that all appeals of decisions of the Registrar of Trademarks made pursuant to subsection 56(1) must be accompanied by a letter to the Registry which:
The Guidelines state that all requests for leave to adduce new evidence will be heard by the applications judge. Further, within 10 days of the appointment of a case management judge, the parties must jointly request a case management conference to determine a schedule for the steps of the proceeding. This includes the timing and manner for determining the leave request, hearing availability for the application, and the timing of appointment of the applications judge.
Summary By: Victoria Di Felice
Disclaimer: This Newsletter is intended to provide readers with general information on legal developments in the areas of e-commerce, information technology and intellectual property. It is not intended to be a complete statement of the law, nor is it intended to provide legal advice. No person should act or rely upon the information contained in this newsletter without seeking legal advice.
E-TIPS is a registered trade-mark of Deeth Williams Wall LLP.